Antipodes Partners’s Booz Allen Hamilton BAH Stock Holding History

Antipodes Partners’s Portfolio BAH Stock Details BAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,409	Closed	-$1.71M	–	117
2025 Q2	$1.71M	Buy	+16,409	New	+$1.84M	0.05%	52
2024 Q4	–	Sell	-13,858	Closed	-$2.26M	–	80
2024 Q3	$2.26M	Sell	13,858 -21,747	-61%	-$3.33M	0.08%	49
2024 Q2	$5.48M	Sell	35,605 -11,415	-24%	-$1.71M	0.2%	41
2024 Q1	$6.98M	Sell	47,020 -61,647	-57%	-$8.68M	0.22%	42
2023 Q4	$13.9M	Buy	108,667 +1,146	+1%	+$143K	0.43%	38
2023 Q3	$11.7M	Sell	107,521 -2,714	-2%	-$312K	0.38%	37
2023 Q2	$12.3M	Sell	110,235 -8,679	-7%	-$858K	0.42%	35
2023 Q1	$11M	Sell	118,914 -74,467	-39%	-$7.06M	0.38%	35
2022 Q4	$20.2M	Buy	193,381 +81	+0%	+$8.42K	0.73%	36
2022 Q3	$17.9M	Buy	+193,300	New	+$18.3M	0.72%	35

Other funds holding BAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Antipodes Partners's BAH Position: Q3 2025 in Review

Antipodes Partners sold out of Booz Allen Hamilton (BAH) in Q3 2025, closing a stake of 16,409 shares — an estimated $1.71M sold.

Antipodes Partners first reported a position in BAH in Q3 2022 and held it in 10 quarters. The position peaked at $20.2M in Q4 2022. 715 funds tracked by Wall St. Rank hold BAH as of Q3 2025.

Antipodes Partners reported no remaining Booz Allen Hamilton position as of Q3 2025 after selling out during the quarter.
Antipodes Partners sold 16,409 Booz Allen Hamilton shares in Q3 2025, an estimated $1.71M.
Antipodes Partners first reported a position in Booz Allen Hamilton in Q3 2022 and held it in 10 quarters.
Antipodes Partners's Booz Allen Hamilton position peaked at $20.2M in Q4 2022.
715 funds tracked by Wall St. Rank held Booz Allen Hamilton as of Q3 2025.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.